Results 171 to 180 of about 22,851 (227)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2023
Abstract Summary Venous thromboembolism (VTE) is a global health burden of which critically unwell patients are at high risk. Current accepted practice and background evidence for the use of mechanical and pharmacological prophylaxis are reviewed.
Emma Louise Hartley, Andrew Retter
openaire +1 more source
Abstract Summary Venous thromboembolism (VTE) is a global health burden of which critically unwell patients are at high risk. Current accepted practice and background evidence for the use of mechanical and pharmacological prophylaxis are reviewed.
Emma Louise Hartley, Andrew Retter
openaire +1 more source
Thromboprophylaxis in multiple myeloma
Leukemia & Lymphoma, 2022Venous thromboembolism (VTE) in multiple myeloma (MM) can be secondary to patient-, disease-, and/or treatment-related factors. The development of VTE may result in significant morbidity with the highest risk during the first year after diagnosis. This clinical review provides an evidence-based summary to guide practicing oncologists in the use of ...
Nishanth, Thalambedu, Samer, Al Hadidi
openaire +2 more sources
Thromboprophylaxis in Microsurgery
Acta Chirurgica Belgica, 2006Microsurgical free tissue transfer has become a gold standard in a wide range of clinical situations. Thrombosis at the anastomotic site is not only the most common cause of failure of microsurgical operations, but it is also one of the factors resulting in microcirculatory intravascular thrombosis in free flaps.
Lecoq, Jean-Pierre +4 more
openaire +2 more sources
Current Opinion in Critical Care, 2008
In trauma patients, pulmonary embolism occurs in up to 4% of cases and carries a mortality of 20-50%. The incidence of deep vein thrombosis (DVT) varies from 5 to 63% depending on patients' risk factors, modality of prophylaxis, and methods of detection.
Bendinelli, Cino, Balogh, Zsolt
openaire +2 more sources
In trauma patients, pulmonary embolism occurs in up to 4% of cases and carries a mortality of 20-50%. The incidence of deep vein thrombosis (DVT) varies from 5 to 63% depending on patients' risk factors, modality of prophylaxis, and methods of detection.
Bendinelli, Cino, Balogh, Zsolt
openaire +2 more sources
Thromboprophylaxis in Pregnancy
Obstetrics and Gynecology Clinics of North America, 2018Venous thromboembolism is a leading cause of maternal morbidity and mortality worldwide. Identifying women who are at greatest risk for venous thromboembolism, and managing their pregnancies with appropriate thromboprophylaxis is essential to decreasing this life-threatening condition. Those at greatest risk are patients with thrombophilias, a personal
Diana, Kolettis, Sabrina, Craigo
openaire +2 more sources
Journal of Thrombosis and Haemostasis, 2010 BACKGROUND: The adequacy of thromboprophylaxis prescriptions in acutely ill hospitalized medical patients needs improvement. OBJECTIVE: To prospectively assess the efficacy of thromboprophylaxis adequacy of various clinical decision support systems (CDSS)
Christian Lovis +2 more
exaly +2 more sources
Thromboprophylaxis in the Cancer Patient
Pathophysiology of Haemostasis and Thrombosis, 1998Thrombosis is a common complication in patients with malignant disease resulting from tumour elaboration of procoagulants and subsequent activation of intravascular coagulation. Cancer therapies (operation, chemotherapy and the use of central venous lines) further heighten the risk of thrombosis.
A K, Kakkar, R C, Williamson
openaire +2 more sources